| RS1349262891 |
ADAR
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1349302999 |
WT1
|
Health Risk |
Likely pathogenic |
— |
| RS1349316725 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS1349317802 |
ADGRG6
|
Health Risk |
Pathogenic |
— |
| RS1349319235 |
RAD50
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1349341137 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Lymphangiomyomatosis |
| RS1349343839 |
PC
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS1349346463 |
ADAR
|
Health Risk |
Pathogenic |
Symmetrical dyschromatosis of extremities, Aicardi-Goutieres syndrome 6 |
| RS1349347394 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS1349358854 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS1349358963 |
CPOX
|
Health Risk |
Pathogenic |
— |
| RS1349370504 |
SLC26A4
|
Health Risk |
Likely pathogenic |
Hearing loss, autosomal recessive |
| RS1349376862 |
KIF5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS1349377950 |
FLNB
|
Health Risk |
Likely pathogenic |
— |
| RS1349385657 |
CEP152
|
Health Risk |
Pathogenic |
Seckel syndrome 5, Seckel syndrome 5 |
| RS1349389319 |
DPM2
|
Health Risk |
Pathogenic |
Congenital muscular dystrophy with intellectual disability and severe epilepsy, Congenital muscular dystrophy with intellectual disability and severe epilepsy |
| RS1349405657 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1349405769 |
NCF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Granulomatous disease, chronic |
| RS1349423783 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1349426679 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia, Hereditary spastic paraplegia 30 |
| RS1349426835 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1349434680 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, CHARGE syndrome |
| RS1349443190 |
NBEAL2
|
Health Risk |
Pathogenic |
Gray platelet syndrome, Malignant tumor of urinary bladder |
| RS1349476281 |
DOK7
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 10, Fetal akinesia deformation sequence 3 |
| RS1349477941 |
KIAA0753
|
Health Risk |
Pathogenic |
— |
| RS1349485235 |
MSX2
|
Health Risk |
Likely pathogenic |
— |
| RS1349488841 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1349494437 |
POMT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2 |
| RS1349506481 |
GRIN2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 27 |
| RS1349510820 |
OTOA
|
Health Risk |
Likely pathogenic |
— |
| RS1349512789 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1349520883 |
PRF1
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Familial hemophagocytic lymphohistiocytosis 2 |
| RS1349528345 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS1349536017 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1349541188 |
COL7A1
|
Health Risk |
Pathogenic |
7 conditions, 7 conditions |
| RS1349581273 |
AXL
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1349597556 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Chédiak-Higashi syndrome, Inborn genetic diseases |
| RS1349623728 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1349637223 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS1349638092 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1349638340 |
MTHFS
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with microcephaly, epilepsy |
| RS1349644537 |
CUBN
|
Health Risk |
Pathogenic/Likely pathogenic |
Imerslund-Grasbeck syndrome, Thymoma |
| RS1349655563 |
F11
|
Health Risk |
Likely pathogenic |
Hereditary factor XI deficiency disease, Plasma factor XI deficiency |
| RS1349667660 |
ABCG8
|
Health Risk |
Pathogenic |
— |
| RS1349668409 |
CDKN1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple endocrine neoplasia type 4, Hereditary cancer-predisposing syndrome |
| RS1349668884 |
DNAAF3
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia 2, Primary ciliary dyskinesia |
| RS1349682845 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1349721736 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1349732291 |
NPHP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis 1, Joubert syndrome with renal defect |
| RS1349733632 |
COL18A1
|
Health Risk |
Likely pathogenic |
— |
| RS1349733778 |
SUMF1
|
Health Risk |
Likely pathogenic |
Multiple sulfatase deficiency, SUMF1-related disorder |
| RS1349734606 |
PLEKHG5
|
Health Risk |
Pathogenic |
Neuronopathy, distal hereditary motor |
| RS1349755445 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS1349765126 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Malignant tumor of breast |
| RS1349800834 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1349804201 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1349812924 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS1349830428 |
KCNH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Temple-Baraitser syndrome, Temple-Baraitser syndrome |
| RS1349838988 |
ARSB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1349849938 |
RDH12
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 13, Retinal dystrophy |
| RS1349879153 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 25 |
| RS1349881223 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS1349881828 |
FANCD2
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group D2 |
| RS1349887620 |
F9
|
Health Risk |
Pathogenic |
Thrombophilia, X-linked |
| RS1349925286 |
SGCG
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS1349928568 |
NBN
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Microcephaly |
| RS1349933620 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Distal myopathy with posterior leg and anterior hand involvement |
| RS1349961118 |
CHEK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1349969572 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS1350002806 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1350031802 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS1350038531 |
PATL2
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 4, Oocyte maturation defect 4 |
| RS1350061017 |
LRBA
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS1350074368 |
MAGEL2
|
Health Risk |
Likely pathogenic |
— |
| RS1350078739 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1350116482 |
NRL
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1350129130 |
ATP8B1
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 1, Progressive familial intrahepatic cholestasis type 1 |
| RS1350129614 |
SMAD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1350147987 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS1350153132 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1350162888 |
BNC2
|
Health Risk |
Pathogenic |
Lower Urinary Tract Obstruction, Lower urinary tract obstruction |
| RS1350177470 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS1350192744 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1350194762 |
NCAPD3
|
Health Risk |
Pathogenic |
Microcephaly 22, primary |
| RS1350201776 |
ZNF335
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Microcephalic primordial dwarfism due to ZNF335 deficiency |
| RS1350203416 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS1350216610 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1350217087 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 2, Long QT syndrome |
| RS1350217989 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS1350227206 |
ACSF3
|
Health Risk |
Pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS1350235037 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS1350257432 |
DPM1
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation type 1E, Congenital disorder of glycosylation type 1E |
| RS1350258866 |
CHD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Snijders Blok-Campeau syndrome, Snijders Blok-Campeau syndrome |
| RS1350266566 |
EXT2
|
Health Risk |
Likely pathogenic |
Exostoses, multiple |
| RS1350288991 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1350303547 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1350323144 |
WHRN
|
Health Risk |
Pathogenic |
— |
| RS1350329646 |
DYNC2H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Jeune thoracic dystrophy, Asphyxiating thoracic dystrophy 3 |
| RS1350329837 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1350342816 |
COL4A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Alport syndrome 3b, autosomal recessive |